1. Home
  2. VRNT vs EVO Comparison

VRNT vs EVO Comparison

Compare VRNT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNT
  • EVO
  • Stock Information
  • Founded
  • VRNT 1994
  • EVO 1993
  • Country
  • VRNT United States
  • EVO Germany
  • Employees
  • VRNT N/A
  • EVO N/A
  • Industry
  • VRNT EDP Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VRNT Technology
  • EVO Health Care
  • Exchange
  • VRNT Nasdaq
  • EVO Nasdaq
  • Market Cap
  • VRNT 1.5B
  • EVO 1.6B
  • IPO Year
  • VRNT N/A
  • EVO 2021
  • Fundamental
  • Price
  • VRNT $24.29
  • EVO $4.44
  • Analyst Decision
  • VRNT Buy
  • EVO Buy
  • Analyst Count
  • VRNT 7
  • EVO 2
  • Target Price
  • VRNT $35.67
  • EVO $5.90
  • AVG Volume (30 Days)
  • VRNT 442.7K
  • EVO 46.1K
  • Earning Date
  • VRNT 03-26-2025
  • EVO 11-06-2024
  • Dividend Yield
  • VRNT N/A
  • EVO N/A
  • EPS Growth
  • VRNT 2980.37
  • EVO N/A
  • EPS
  • VRNT 0.95
  • EVO N/A
  • Revenue
  • VRNT $920,749,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • VRNT $4.50
  • EVO $3.84
  • Revenue Next Year
  • VRNT $4.50
  • EVO $10.94
  • P/E Ratio
  • VRNT $25.33
  • EVO N/A
  • Revenue Growth
  • VRNT 4.45
  • EVO N/A
  • 52 Week Low
  • VRNT $21.28
  • EVO $2.85
  • 52 Week High
  • VRNT $38.17
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • VRNT 37.65
  • EVO 49.82
  • Support Level
  • VRNT $25.48
  • EVO $4.40
  • Resistance Level
  • VRNT $26.62
  • EVO $4.49
  • Average True Range (ATR)
  • VRNT 0.87
  • EVO 0.10
  • MACD
  • VRNT -0.08
  • EVO -0.00
  • Stochastic Oscillator
  • VRNT 12.46
  • EVO 38.46

About VRNT Verint Systems Inc.

Verint Systems Inc with its subsidiaries helps brands provide Boundless Customer Engagement. The company's solutions help iconic brands close the gap created when it lacks the resources required to deliver experiences that fulfill customer expectations. Geographically, it derives a majority of its revenue from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: